SCHEMBL12285647

SCHEMBL12285647

CC(C)(C)COc1cc(C(=O)O)cc(C(=O)O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 1/20 0.50
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ NR4A2 P43354 3/20 0.41
▸ NR4A1 P22736 1/20 0.41
▸ NR4A3 Q92570 1/20 0.41
▸ XDH P47989 1/20 0.40
▸ POLB P06746 2/20 0.40
▸ GPBAR1 Q8TDU6 1/20 0.39
▸ TPMT P51580 1/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ BRD2 P25440 1/20 0.38
▸ CREBBP Q92793 1/20 0.38
▸ RXRA P19793 1/20 0.38
▸ RXRB P28702 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17089124 0.84 KMT2A (0.50) PLA2G2AKMT2AMEN1NR4A2POLB
SCHEMBL27893393 0.81 L3MBTL1 (0.51) PLA2G2AKMT2AMEN1NR4A2RXRA
SCHEMBL2196744 0.81 NR4A2 (0.57) NR4A2NR4A1NR4A3POLBRXRA
SCHEMBL4736069 0.81 MEN1 (0.41) PLA2G2AKMT2AMEN1POLBBRD4
SCHEMBL18658364 0.80 GABRA1 (0.38) PLA2G2ACA12CA1CA2CA9
SCHEMBL3184334 0.78 PLA2G2A (0.59) PLA2G2AKMT2AMEN1POLBBRD4
SCHEMBL977465 0.77 MAPT (0.55) PLA2G2AKMT2AMEN1NR4A2RXRA
SCHEMBL17029392 0.76 PLA2G2A (0.43) PLA2G2AKMT2AMEN1NR4A2POLB
SCHEMBL13449771 0.76 ALDH1A1 (0.44) KMT2AMEN1XDH
SCHEMBL28529167 0.75 PLA2G2A (0.67) PLA2G2AKMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883378-B2 Colored curable composition, color filter and method of producing color filter, solid-state image sensor and liquid crystal display device FUJIFILM CORPORATION (JP) 2014-11-11 — — US disclosed
US-8815478-B2 Colored curable composition, resist liquid, ink for inkjet printing, color filter, method of producing color filter, solid-state image sensor, liquid crystal display, organic EL display, image display device and colorant compound FUJIFILM CORPORATION (JP) 2014-08-26 — — US disclosed
US-8637215-B2 Colored curable composition, color filter and method of producing color filter, solid-state image sensor and liquid crystal display device FUJIFILM CORPORATION (JP) 2014-01-28 — — US disclosed
US-20120264039-A1 COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND FUJIFILM CORPORATION (JP) 2012-10-18 — — US disclosed
US-20110217636-A1 COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2011-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264039-A1 COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND CDYL, RET, NLRP1 PLA2G2A 4433/4885KMT2A 881/4885MEN1 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback